Form 4 for VOR Vor Biopharma Inc.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-17 · accession 0001415889-25-020551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-30 | 2025-07-17 | VOR | Zuraw Qing Che | Chief Development Off | A - Grant | $0.00 | +937.1K | 937.1K | New | $0 |
| D | 2025-07-30 | 2025-07-17 | VOR | Zuraw Qing Che | Chief Development Off | A - Grant | $0.00 | +4.37M | 4.37M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-17 | A | A | 937,080 | $0.00 | 937,080 | D | — | — | (F1) Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on August 1, 2026, with the remainder vesting in substantially equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-07-17 | A | A | 4,373,040 | $0.00 | 4,373,040 | D | $2.38 · — to 2035-07-16 | 4,373,040 Common Stock | (F2) 1/4th of the shares underlying the option vest on July 17, 2026, with the remainder vesting in substantially equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date. |